ExThera Medical develops revolutionary medical devices that address unmet clinical needs in the treatment of bloodstream infections.
Location: United States, California, Martinez
Phone: +1 925-839-2060
Total raised: $19.05M
Investors 3
| Date | Name | Website |
| - | Cycad Grou... | cycadvc.co... |
| - | Fraser Fin... | fraserfina... |
| - | NaHCO3 | nahco3.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.06.2016 | - | $15.3M | - |
| 06.10.2014 | - | $3.75M | - |
Mentions in press and media 6
| Date | Title | Description |
| 03.06.2016 | Blood Filtering Tech Developer ExThera Medical Raises $15.3M | ExThera Medical Corporation, a Martinez, CA-based developer of innovative blood filtering technology, closed a $15.3m Series B financing round. The round was led by new investor Fresenius Medical Care Ventures with participation from existi... |
| 07.12.2015 | ExThera Medical wins approval for a CE Mark trial for its Seraph blood filter | “Since its inception ExThera’s mission has been to offer simple, device-based therapies for rapid treatment of bloodstream infections – including those caused by pathogens for which there are no effective therapeutic drugs,” added chief tec... |
| 08.12.2014 | ExThera unveils promising data for ‘superbug’ device | ExThera Medical unveiled promising data from a study of its Seraph blood-filtering device in the treatment of drug-resistant strains of E. coli and pneumonia. Laboratory tests showed the device’s absorption media was able to remove 99.9% of... |
| 06.10.2014 | ExThera Medical Completes $3.75M Convertible Note Offering | ExThera Medical Corporation, a Berkeley, Calif.-based medical device company, completed a $3.75m first closing of its $7m convertible note offering. The company intends to use the funds to complete the first clinical trial and commercialize... |
| - | ExThera Medical | “Seraph 100 Microbind Affinity Blood Filter is a revolutionary hemoperfusion medical device that addresses unmet clinical needs in treating bloodstream infections and reducing pathogens” |
| - | ExThera Medical wins approval for a CE Mark trial for its Seraph blood filter | Berkeley, Calif.-based ExThera Medical has announced approval for a CE Mark trial for its Seraph blood filter device. The filter designed to remove pathogens from the bloodstream, specifically when treating dialysis patients with Staphyloco... |